Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study.

Abstract:

:Multiple sources were used to identify 325 systemic lupus erythematosus (SLE) patients within the city of Oslo during 1999-2009 who met ≥ 4 of the American College of Rheumatology (ACR) criteria. The survival, standard mortality rate (SMR), years of potential life loss before 60 years of age (YPLL60) and causes of death of these patients were examined and compared to a matched control population. Only inception cases (127) were studied in the calculation of survival. The analysis includes underlying, immediate and contributing causes of death. The five- and 10-year survival was 95% and 90%, respectively, which was significantly reduced when compared to the general population. A total of 50 SLE patients died during the study period. Overall SMR was 3.0 (95% confidence interval (CI) 2.2-3.8) with the highest SMR found for female patients aged 16-39 years old. SLE patients had a 10 times higher rate of YPLL60 compared to the control group. YPLL emphasizes active disease and reduces the importance of cancer as a cause of death in SLE. This study demonstrates that YPLL gives additional and useful information for the prognosis of SLE, supplementing traditional methods of measuring mortality.

journal_name

Lupus

journal_title

Lupus

authors

Lerang K,Gilboe IM,Steinar Thelle D,Gran JT

doi

10.1177/0961203314551083

subject

Has Abstract

pub_date

2014-12-01 00:00:00

pages

1546-52

issue

14

eissn

0961-2033

issn

1477-0962

pii

0961203314551083

journal_volume

23

pub_type

杂志文章

相关文献

LUPUS文献大全
  • A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab.

    abstract::Belimumab is a monoclonal antibody against soluble B-lymphocyte stimulator, an essential growth factor for B-cell maturation and activation, which was approved by the US FDA in 2011 for patients with active autoantibody-positive systemic lupus erythematosus (SLE) who have failed standard treatment. Here we present the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314524292

    authors: Fredericks CA,Kvam KA,Bear J,Crabtree GS,Josephson SA

    更新日期:2014-06-01 00:00:00

  • Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.

    abstract::Objectives The aim of this study was to study the relationship between immunosuppressive drug treatment and survival in patients with systemic lupus erythematosus (SLE). Methods Patients who fulfilled four or more American College of Rheumatology criteria for SLE were followed longitudinally. Clinical characteristics,...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317739129

    authors: Mok CC,Tse SM,Chan KL,Ho LY

    更新日期:2018-04-01 00:00:00

  • Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.

    abstract::We report a woman with systemic lupus erythematosus (SLE) with diffuse proliferative glomerulonephritis and anti-dsDNA antibodies whose serum contained autoantibodies specific for the phosphorylated form of RNA polymerase II (RNAP IIO), Su and ribosomal P antigen, as well as anti-topoisomerase I antibodies, a marker f...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400414

    authors: Stojanov L,Satoh M,Dooley MA,Kuwana M,Jennette JC,Reeves WH

    更新日期:1995-08-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • SLEDAI-2K for a 30-day window.

    abstract::The aim of our study was to determine whether the SLEDAI-2K calculated using a timeframe of 30 days prior to a visit for clinical and laboratory variables was equivalent to the prescribed 10-day period. One hundred forty nine consecutive lupus patients seen over 9 weeks at the University of Toronto Lupus Clinic enroll...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309346505

    authors: Touma Z,Urowitz MB,Gladman DD

    更新日期:2010-01-01 00:00:00

  • Pregnancy and patients with preexisting lupus nephritis: 15 years of experience at a single center in Korea.

    abstract::We investigated obstetric outcomes and comorbidities during pregnancy in females with preexisting lupus nephritis (LN) and identified predictors for renal flare. In cases of renal flare during pregnancy, we assessed the long-term post-delivery renal outcome. We performed a retrospective analysis of 183 systemic lupus ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315572715

    authors: Koh JH,Ko HS,Lee J,Jung SM,Kwok SK,Ju JH,Park SH

    更新日期:2015-06-01 00:00:00

  • Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS).

    abstract:BACKGROUND:Ferritin is an iron storage protein considered also as an acute phase reactant with high levels in various inflammatory conditions. Recently, a plausible role for ferritin in the pathogenesis of immune-mediated and especially autoimmune diseases has been suggested. However, the link between ferritin and the ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313504633

    authors: Agmon-Levin N,Rosário C,Katz BS,Zandman-Goddard G,Meroni P,Cervera R,Stojanovich L,Blank M,Pierangeli S,Praprotnik S,Meis Ed,Seguro LP,Ruffatti A,Pengo V,Tincani A,Doria A,Shoenfeld Y

    更新日期:2013-11-01 00:00:00

  • Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association.

    abstract::This report considers the rare situation in which primary antiphospholipid syndrome (PAPS) is linked with thrombotic thrombocytopenic purpura (TTP). It describes the case of a young lady with PAPS, characterized by recurring cerebro-vascular abnormalities and marked livedo reticularis, combined with circulating antica...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308101958

    authors: de Carvalho JF,Freitas CA,Lima IV,Leite CC,Lage LV

    更新日期:2009-08-01 00:00:00

  • Familial SLE: sustained drug-free remission in a mother successfully treated for anal cancer, but development of SLE in a 16-year old daughter.

    abstract::The immunopathogenesis of systemic lupus erythematosus has been thoroughly investigated recently, and genome-wide association studies have identified genes statistically associated with lupus. However, the progression to overt disease is dependent on the activation of environmental factors ('triggers'), among which oe...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311433138

    authors: Catania G,Rossi E,Marmont A

    更新日期:2012-05-01 00:00:00

  • Revisiting the anticardiolipin test and its standardization.

    abstract::Although the importance of the anticardiolipin test in diagnosis of antiphospholipid syndrome (APS) is widely accepted, there remains much misunderstanding about the strengths and weaknesses of this assay. Several disorders result in formation of low levels of the antibody, hence the anticardiolipin test is not specif...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu202cr

    authors: Harris EN,Pierangeli SS

    更新日期:2002-01-01 00:00:00

  • Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

    abstract::Tissue damage associated with a severe injury can result in profound inflammatory responses that may trigger autoimmune development in lupus-prone individuals. In this study, we investigated the role of a large full-thickness cutaneous burn injury on the early onset of autoimmune disease in lupus-prone MRL/++ mice. MR...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097479

    authors: Anam K,Amare M,Naik S,Szabo KA,Davis TA

    更新日期:2009-04-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00

  • Antiphospholipid antibodies in alcoholic liver disease are influenced by histological damage but not by alcohol consumption.

    abstract::Antiphospholipid antibodies (aPL) have been detected in various liver diseases, particularly cirrhosis. The role of alcoholic consumption per se has been suggested. The aim of our study was to assess the prevalence of aPL in patients with alcoholic liver disease at various states and to correlate the presence of aPL w...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828659

    authors: Perney P,Biron-Andréani C,Joomaye Z,Fabbro-Peray P,Quénet F,Schved JF,Blanc F

    更新日期:2000-01-01 00:00:00

  • Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy.

    abstract::A 26-year-old Japanese woman developed autoimmune pulmonary alveolar proteinosis (PAP) during glucocorticoid therapy for systemic lupus erythematosus (SLE). Intensive immunosuppressive therapy worsened the PAP. De-escalation of immunosuppressive therapy improved the PAP. Autoimmune PAP is rarely associated with system...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313498798

    authors: Nagasawa J,Kurasawa K,Maezawa R,Owada T,Hanaoka R,Fukuda T

    更新日期:2013-09-01 00:00:00

  • Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.

    abstract::The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the first-line therapies and by relapses after initial clinical remission. In these patients, second-line drugs are often prescribed according to individual clinical decis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309106174

    authors: Ramos-Casals M,Soto MJ,Cuadrado MJ,Khamashta MA

    更新日期:2009-08-01 00:00:00

  • A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives.

    abstract::Sera from healthy individuals, relatives of lupus patients, and lupus patients with active disease and in remission were screened for IgG and IgM antibodies to ssDNA and dsDNA. The serum samples were also separated into IgG and IgM fractions which were screened for DNA reactivity at dilutions equivalent to those used ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500604

    authors: Williams WM,Isenberg DA

    更新日期:1996-12-01 00:00:00

  • Vulvar intraepithelial neoplasia in a young woman with systemic lupus erythematosus: a case report.

    abstract::Diagnosing vulvar intraepithelial neoplasia in a young woman presenting mainly with skin manifestations of lupus and with no other risk factors is a major challenge. The case of a 27-year-old woman with systemic lupus erythematosus and vulvar intraepithelial neoplasia is described. Although progression of vulvar intra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345742

    authors: Stepanić V,Corusić A,Matković V,Sentić M,Bosnić D,Mahovlić V

    更新日期:2010-01-01 00:00:00

  • Risk of complications of ultrasound-guided renal biopsy for adult and pediatric patients with systemic lupus erythematosus.

    abstract::Objective The objective of this paper is to identify the risk of complications of real-time ultrasound-guided renal biopsy in adult and pediatric patients with systemic lupus erythematosus (SLE). Materials and methods This retrospective study examined outcomes of 296 renal biopsy procedures in 275 SLE patients. Imagin...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317751048

    authors: Sun YS,Sun IT,Wang HK,Yang AH,Tsai CY,Huang CJ,Huang DF,Lai CC

    更新日期:2018-04-01 00:00:00

  • Apoptosis in the pathogenesis of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a prototype inflammatory autoimmune disease resulting from autoimmune responses against nuclear autoantigens. During apoptosis many lupus autoantigens congregate inside the cells and are susceptible to modifications. Modified nuclear constituents are considered foreign and dangero...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308089990

    authors: Munoz LE,van Bavel C,Franz S,Berden J,Herrmann M,van der Vlag J

    更新日期:2008-05-01 00:00:00

  • Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity.

    abstract::With a cross sectional study of 465 consecutive systemic lupus erythematosus (SLE) patients tested for 13 autoantibodies (Aab) and two idiotypes we determined the prevalence of Aab according to disease activity, both general and at particular organ systems. Seventy seven percent of SLE sera had at least one Aab and 56...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600503

    authors: Villarreal GM,Drenkard C,Villa AR,Slor H,Shafrir S,Bakimer R,Shoenfeld Y,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.

    abstract::Immune-mediated sensorineural hearing loss may complicate systemic autoimmune diseases. We have previously reported the presence of antibodies directed against inner ear antigens in patients with Cogan syndrome, a disease characterized by sudden hearing loss and interstitial keratitis. Such autoantibodies cross-react ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316682099

    authors: Bason C,Pagnini I,Brucato A,Maestroni S,Puccetti A,Lunardi C,Cimaz R

    更新日期:2017-07-01 00:00:00

  • Antiphospholipid syndrome and tissue factor: a thrombotic couple.

    abstract::The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). Among the thrombogenic mechanisms proposed, it has been suggested that aPL can stimulate tissue factor (TF) expression by endothelial cells (ECs) and monocytes. Moreover, ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203306lu2276rr

    authors: López-Pedrera Ch,Buendía P,Aguirre MA,Velasco F,Cuadrado MJ

    更新日期:2006-01-01 00:00:00

  • Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases.

    abstract::Q fever has extremely polymorphic features, and has been reported to be associated with positivity of several autoimmune antibodies. We report two cases of atypical Q fever with a clinical presentation highly suggestive of an inflammatory systemic disease with positivity of autoimmune antibodies, mimicking systemic lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317747721

    authors: Durupt S,Puget M,Lega JC,Durieu I,Reynaud Q

    更新日期:2017-01-01 00:00:00

  • Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.

    abstract:OBJECTIVE:To investigate the predictive value of serum C3 and C4 complement component levels in relation to pregnancy outcome in patients with antiphospholipid syndrome (APS). MATERIALS AND METHODS:A prospective study of 47 pregnancies associated with APS was performed. Pregnancy outcome was analyzed in terms of: feta...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312444172

    authors: De Carolis S,Botta A,Santucci S,Salvi S,Moresi S,Di Pasquo E,Del Sordo G,Martino C

    更新日期:2012-06-01 00:00:00

  • Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome.

    abstract::Diagnostic strategy studies commonly focus on the accuracy of tests in diagnosing, and grading this body of evidence is a challenge in itself because (1) standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing; and (2) the clinical usefulness of a diagnostic strat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543922

    authors: Mendes de Abreu M,Levy RA,Wahl D

    更新日期:2014-10-01 00:00:00

  • Protein S deficiency revealed by skin necrosis in a patient with lupus.

    abstract::Protein S deficiency is rare in systemic lupus erythematosus (SLE) and is generally associated with the presence of antiphospholipid (APL) antibodies. Lack of protein S can cause skin necrosis, but when it does it is generally in response to warfarin exposure. In this article, we describe the case of a patient who had...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319843345

    authors: Plana-Pla A,Bielsa Marsol I,Ferrandiz Foraster C

    更新日期:2019-06-01 00:00:00

  • Anti-glycan antibodies as biomarkers for diagnosis and prognosis.

    abstract::Glycans (sugars or carbohydrates) are predominant surface components of cells such as erythrocytes, immune cells and microorganisms. As such, they give rise to high levels of anti-glycan antibodies of all classes. Antibodies to certain defined mono, di and oligosaccharides that are common in bacterial, fungal and para...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203306lu2331oa

    authors: Dotan N,Altstock RT,Schwarz M,Dukler A

    更新日期:2006-01-01 00:00:00

  • Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus.

    abstract::To assess bladder function in systemic lupus erythematosus (SLE) patients with recurrent urinary tract infections (UTIs). A convenience sample of consecutive patients with SLE (American College of Rheumatology criteria), with recurrent UTIs (>/=3 events in the preceding 12 months), without history of central nervous s...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308093458

    authors: Duran-Barragan S,Ruvalcaba-Naranjo H,Rodriguez-Gutierrez L,Solano-Moreno H,Hernandez-Rios G,Sanchez-Ortiz A,Ramos-Remus C

    更新日期:2008-12-01 00:00:00

  • Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy.

    abstract::We studied the effect of beta 2-GPI on binding of antibodies in sera from patients with leprosy and patients with the antiphospholipid syndrome (APS) to CL in enzyme-linked immunosorbent assays (ELISAs). Increased levels of IgG aCL were detected in 59 of 61 leprosy patients' sera by the standard aCL-ELISA in the prese...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300615

    authors: Hojnik M,Gilburd B,Ziporen L,Blank M,Tomer Y,Scheinberg MA,Tincani A,Rozman B,Shoenfeld Y

    更新日期:1994-12-01 00:00:00